Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-24-018171
Filing Date
2024-04-25
Accepted
2024-04-25 16:10:33
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2024defa14a.htm DEFA14A 25629
2 gb-pg1.jpg GRAPHIC 228822
3 gb-pg2.jpg GRAPHIC 195446
4 image_0.jpg GRAPHIC 41860
  Complete submission text file 0001628280-24-018171.txt   669101
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35558 | Film No.: 24876381
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)